Scarica l'app Stockscreener
4.43
2.84%
0.1222
Precedente Chiudi:
$4.3078
Aprire:
$4.42
Volume 24 ore:
11,033
Relative Volume:
0.94
Capitalizzazione di mercato:
$6.77M
Reddito:
$5.67M
Utile/perdita netta:
$-13.98M
Rapporto P/E:
-0.3135
EPS:
-14.13
Flusso di cassa netto:
$-15.30M
1 W Prestazione:
+1.84%
1M Prestazione:
-5.94%
6M Prestazione:
-25.17%
1 anno Prestazione:
+42.90%
Intervallo 1D:
$4.3453
$4.4897
Intervallo di 1 settimana:
$4.13
$4.60
Portata 52W:
$2.40
$10.31
Arcadia Biosciences Inc Stock (RKDA) Company Profile
Nome
Arcadia Biosciences Inc
Settore
Industria
Telefono
530-756-7077
Indirizzo
202 COUSTEAU PLACE, DAVIS, CA
Confronta RKDA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RKDA
Arcadia Biosciences Inc
|
4.43 | 6.77M | 5.67M | -13.98M | -15.30M | -14.13 |
|
KHC
Kraft Heinz Co
|
26.61 | 31.47B | 25.43B | 2.66B | 3.03B | 2.19 |
|
JBS
Jbs N V
|
14.21 | 30.77B | 88.95B | 2.16B | 374.50M | 0.9748 |
|
GIS
General Mills Inc
|
53.19 | 29.84B | 19.64B | 2.56B | 2.48B | 4.55 |
|
K
Kellanova
|
79.86 | 28.25B | 12.63B | 1.38B | 863.00M | 3.96 |
|
MKC
Mccormick Co Inc
|
77.17 | 20.28B | 6.68B | 792.60M | 774.40M | 2.94 |
Arcadia Biosciences Inc Stock (RKDA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2020-08-17 | Reiterato | H.C. Wainwright | Buy |
| 2017-05-12 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2015-06-09 | Iniziato | Credit Suisse | Outperform |
| 2015-06-09 | Iniziato | Piper Jaffray | Overweight |
Arcadia Biosciences Inc Borsa (RKDA) Ultime notizie
Arcadia Biosciences, Inc. (NASDAQ:RKDA) Short Interest Update - Defense World
Arcadia Biosciences (NASDAQ:RKDA) Now Covered by Analysts at StockNews.com - Defense World
Arcadia Biosciences faces default on $2M note payment By Investing.com - Investing.com Nigeria
Arcadia Biosciences faces default on $2M note payment - Investing.com
Arcadia Biosciences Faces Payment Default from Above Food - TipRanks
Arcadia Biosciences Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits - Quantisnow
SEC Form 4 filed by Chief Financial Officer Kawakami Mark - Quantisnow
SEC Form 4 filed by Chief Executive Officer Schaefer Thomas J. - Quantisnow
Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q1 2025 Earnings Call Transcript - Insider Monkey
Arcadia Biosciences Reports Strong Growth Amid Challenges - TipRanks
Arcadia Biosciences: Q1 Earnings Snapshot - New Haven Register
Arcadia Biosciences Inc (RKDA) Q1 2025 Earnings Call Highlights: Strong Zola Sales and ... - Yahoo Finance
Arcadia Biosciences Inc (RKDA) Q1 2025 Earnings Call Highlights: Strong Zola Sales and Strategic Moves Amid Challenges - GuruFocus
Earnings call transcript: Arcadia Biosciences sees Q1 2025 revenue rise 22% - Investing.com
Arcadia Biosciences (RKDA) Announces First Quarter 2025 Financial Results and Business Highlights - GlobeNewswire
Arcadia Biosciences Q1 Earnings Preview - MSN
Arcadia Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
Arcadia Climbs on Q1 Figures - Baystreet.ca
ARCADIA BIOSCIENCES Earnings Results: $RKDA Reports Quarterly Earnings - Nasdaq
Arcadia Biosciences (RKDA) Announces First Quarter 2025 Financial Results and Business Highlights | RKDA Stock News - GuruFocus
Arcadia Biosciences, Inc. SEC 10-Q Report - TradingView
Arcadia Biosciences Inc (RKDA) Q1 2025 Earnings Report Preview: What To Expect - GuruFocus
Geode Capital Management LLC Takes $73,000 Position in Arcadia Biosciences, Inc. (NASDAQ:RKDA) - Defense World
Halper Sadeh LLP, Arcadia Biosciences, Inc., The Interpublic Group of Companies, Inc., Omnicom Group Inc., Enterprise Bancorp, Inc. - Olean Times Herald
Arcadia Biosciences (NASDAQ:RKDA) Earns Sell Rating from Analysts at StockNews.com - Defense World
Arcadia Biosciences (RKDA) Announces Date of First Quarter 2025 - GuruFocus
Arcadia Biosciences, Inc. Announces Q1 2025 Financial Results Release and Conference Call Schedule - Nasdaq
Arcadia Biosciences (RKDA) Announces Date of First Quarter - GlobeNewswire
Mark Your Calendar: Arcadia Biosciences to Reveal Q1 2025 Financial Performance on May 8 - Stock Titan
Press Release Distribution & PR Platform - ACCESS Newswire
Arcadia Biosciences (NASDAQ:RKDA) Research Coverage Started at StockNews.com - The AM Reporter
Arcadia Biosciences (NASDAQ:RKDA) Now Covered by StockNews.com - Defense World
Arcadia Biosciences (NASDAQ:RKDA) Coverage Initiated by Analysts at StockNews.com - The AM Reporter
Arcadia Biosciences regains IP rights, amends agreement By Investing.com - Investing.com India
Arcadia Biosciences regains IP rights, amends agreement - Investing.com
Arcadia Biosciences IncEnters Agreement To Transfer Patents And Rights With A Third Party- SEC Filing - MarketScreener
Head-To-Head Contrast: Lendway (NASDAQ:LDWY) versus Arcadia Biosciences (NASDAQ:RKDA) - The AM Reporter
Arcadia Biosciences (NASDAQ:RKDA) vs. Lendway (NASDAQ:LDWY) Critical Analysis - Defense World
Arcadia Biosciences Inc. (RKDA) reports earnings - qz.com
Arcadia Biosciences outlines 2025 growth potential for Zola after 46% sales increase in 2024 - MSN
Arcadia Biosciences, Inc. (NASDAQ:RKDA) Q4 2024 Earnings Call Transcript - Insider Monkey
Arcadia Biosciences Inc Azioni (RKDA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Arcadia Biosciences Inc Azioni (RKDA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Schaefer Thomas J. | Chief Executive Officer |
Feb 03 '25 |
Buy |
2.49 |
700 |
1,743 |
2,819 |
| Kawakami Mark | Chief Financial Officer |
Aug 01 '24 |
Buy |
2.06 |
700 |
1,442 |
1,981 |
| Schaefer Thomas J. | Chief Executive Officer |
Aug 01 '24 |
Buy |
2.06 |
700 |
1,442 |
2,119 |
3.39%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):